A new study has found that much-hyped Hydroxychloroquine has not been able to prevent SARS-CoV-2 infection among healthcare workers. The US government has been promoting Hydroxychloroquine as a potential miracle drug that can ward off the coronavirus. The Trump government has procured a large amount of Hydroxychloroquine from overseas to contain the COVID19 pandemic. However, the President’s effort to curb the spread of the virus has not materialized entirely. This study has been conducted at two urban hospitals in the US. Around 132 full-time healthcare workers who have contracted the virus have been included in the study. The volunteers of the study have been observed for four months.
The participants have been divided into two groups during the study. The first group has been given 600 mg daily doses of Hydroxychloroquine. At the same time, the second group was given a placebo for 8 weeks. Experts have found that there has been no major difference in the rate of infection between the participants who have been given Hydroxychloroquine and those who have received just a placebo. Nearly 64 of the participants who have taken Hydroxychloroquine have been diagnosed with COVID19 infection. Around four of the 61 healthcare workers who have been given a placebo have tested positive for the disease.
Few of the participants who have been tested positive for COVID19 have developed viral symptoms, said the experts. According to the study, none of the participants who have tested positive for the disease has been hospitalized. All of them have recovered from the disease clinically. Experts have claimed that Hydroxychloroquine cannot be recommended for routine use among healthcare workers, who have been tested positive for COVID19. Some of the doctors have warned people that the drug can cause serious heart issues as well. This study has been published in the Journal of JAMA Internal Medicine. The findings of the new study are quite similar to a previous study, which has been published in the New England Journal of Medicine.